Marizomib (Salinosporamide A) is a second-generation, irreversible, brain-penetrant, pan-proteasome inhibitor. Marizomib inhibits the CT-L (beta5), CT-T-laspase-like (C-L, beta1) and trypsin-like (T-L, beta2) activities of the 20S proteasome (IC50=3.5, 28, and 430 nM, respectively)[1][2][3].
Molecular Weight:
313.78
Purity:
99.13
CAS Number:
[437742-34-2]
Formula:
C15H20ClNO4
Target:
Proteasome
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
